Digitale Bibliotheek
Sluiten Bladeren door artikelen uit een tijdschrift
     Tijdschrift beschrijving
       Alle jaargangen van het bijbehorende tijdschrift
         Alle afleveringen van het bijbehorende jaargang
                                       Alle artikelen van de bijbehorende aflevering
 
                             323 gevonden resultaten
nr titel auteur tijdschrift jaar jaarg. afl. pagina('s) type
1 Abdominal ultrasonography for conformal high-dose-rate intracavitary brachytherapy in carcinoma of the cervix Mahantshetty, Umesh M.
2008
7 2 p. 149-150
2 p.
artikel
2 Accelerated partial breast irradiation with the SenoRx balloon brachytherapy catheter: Preclinical treatment planning assessment Dorin, A. Todor
2008
7 2 p. 130-
1 p.
artikel
3 A comparison between ultrasound-based real time vs conventional ct-based treatment plan in high-dose-rate brachytherapy for prostate Pokharel, Shyam
2008
7 2 p. 189-190
2 p.
artikel
4 A comparison of biochemical relapse-free survival in patients with high-risk prostate cancer treated with permanent seed implant monotherapy, radical prostatectomy, or external beam radiotherapy Koyfman, Shlomo A.
2008
7 2 p. 98-
1 p.
artikel
5 A comparison of post-implant day 0 vs. day 30 dosimetry for LDR interstitial transperineal prostate brachytherapy Biagioli, Matthew
2008
7 2 p. 180-
1 p.
artikel
6 Acute toxicity of single fraction high-dose-rate brachytherapy with hypofractionated external beam radiotherapy in intermediate-risk prostate cancer Kamran, Asim
2008
7 2 p. 122-
1 p.
artikel
7 Adding MRI-based 3D brachytherapy dose distributions to 3D IMRT dose distributions in cervical cancer patients Van de Kamer, Jeroen B.
2008
7 2 p. 123-124
2 p.
artikel
8 Additional upper rectal and/or recto-sigmoid mucosal points and doses in high-dose-rate intracavitary brachytherapy for carcinoma of the cervix – a dosimetric study Mahantshetty, Umesh
2008
7 2 p. 149-
1 p.
artikel
9 Adjuvant high-dose-rate intravaginal brachytherapy for intermediate- and high-risk stage IB-IIB endometrial cancer: The University of Iowa experience Duncan, Casey E.
2008
7 2 p. 153-154
2 p.
artikel
10 Adjuvant vaginal brachytherapy alone for high-risk localized endometrial cancer as defined by PORTEC, GOG 99, and Aalders McCloskey, Susan A.
2008
7 2 p. 109-
1 p.
artikel
11 A dose planning study on applicator-guided stereotactic IMRT boost in combination with 3D MRI-based brachytherapy in locally advanced cervical cancer Tanderup, Kari
2008
7 2 p. 114-
1 p.
artikel
12 A dosimetric comparison of prostate brachytherapy implant characteristics using linked seeds with and without spacers Lee, Haidy L.
2008
7 2 p. 193-
1 p.
artikel
13 A dosimetric comparison of three different brachytherapy applicators for partial breast irradiation Gurdalli, Salih
2008
7 2 p. 143-
1 p.
artikel
14 A dosimetric comparison of two high-dose-rate brachytherapy planning systems in cervix cancer: Standardized template planning versus computerized treatment planning Patone, Hassisen
2008
7 2 p. 126-
1 p.
artikel
15 A dosimetric comparison of Xoft Axxent Electronic Brachytherapy™ and Ir-192 HDR brachytherapy in the treatment of endometrial cancer Dickler, Adam
2008
7 2 p. 154-
1 p.
artikel
16 A dosimetric comparison of Xoft Axxent Electronic BrachytherapyTM and Ir-192 HDR interstitial brachytherapy in the treatment of cervical cancer Kirk, Michael C.
2008
7 2 p. 153-
1 p.
artikel
17 American Society of Breast Surgeons MammoSite® Registry: Ductal carcinoma in-situ subset – three-year data in 194 cancers Keisch, Martin
2008
7 2 p. 104-105
2 p.
artikel
18 A multi-slit phantom for quality assurance of afterloaders Siebert, Frank-Andre
2008
7 2 p. 171-
1 p.
artikel
19 Analysis of high-dose-rate interstitial brachytherapy dose plans for treatment of localized breast carcinoma Nair, Murali
2008
7 2 p. 142-
1 p.
artikel
20 Analysis of high dose region distribution as a basis for inverse planning concepts used in intracavitary/interstitial cervix cancer brachytherapy Tnkova, Petra
2008
7 2 p. 147-
1 p.
artikel
21 A new shielding method for 192Ir MammoSite brachytherapy for using the microSelectron HDR Lopez, Victor A.
2008
7 2 p. 145-146
2 p.
artikel
22 An MRI scanner compatible implant robot for prostate brachytherapy Moerland, Marinus A.
2008
7 2 p. 100-
1 p.
artikel
23 A novel calibration procedure of MOSFET dosimeters for use to measure in-vivo doses during HDR 192Ir brachytherapy Sabbas, Albert
2008
7 2 p. 169-
1 p.
artikel
24 A novel method for inverse planning using Monte Carlo dose calculations in afterloading brachytherapy Michel, D'Amours
2008
7 2 p. 172-173
2 p.
artikel
25 A novel MRI-based approach to prostate brachytherapy Frank, Steven J.
2008
7 2 p. 101-102
2 p.
artikel
26 A novel technique of intracavitary 125Iodine brachytherapy for vertebral body metastases Cesaretti, Jamie A.
2008
7 2 p. 164-165
2 p.
artikel
27 APBI outside the box: Outcome analyses in “high-risk” patients eligible for the NSABP B-39/RTOG 0413 trial Hodge, Charles
2008
7 2 p. 112-
1 p.
artikel
28 A phase III randomized trial of meloxicam started either 1 week prior to or concurrent with Iodine-125 prostate brachytherapy to reduce post-implant edema, catheterization rates and the severity of lower urinary tract symptoms Crook, Juanita M.
2008
7 2 p. 115-
1 p.
artikel
29 Applicator reconstruction accuracy on standard T2-weighted fast spin echo and 3D T2-weighted fast recovery fast spin echo sequence Hudej, Robert
2008
7 2 p. 171-
1 p.
artikel
30 Applicator reconstruction in MRI 3D image-based dose planning of brachytherapy for cervical cancer Haack, Soren
2008
7 2 p. 167-
1 p.
artikel
31 Applying dosimetric benchmarks to low-dose-rate prostate brachytherapy in the community setting: Ready for prime time? Papagikos, Michael A.
2008
7 2 p. 176-
1 p.
artikel
32 A preliminary report on AAPM guidelines on the physics of dose prescription and reporting methods for permanent interstitial brachytherapy for prostate cancer Nath, Ravinder
2008
7 2 p. 132-
1 p.
artikel
33 Are we hitting the target and if not, can we safely alter the pear? Kelly, Tracy
2008
7 2 p. 108-
1 p.
artikel
34 ASCENDE-RT∗, a randomized trial of brachytherapy: First report of the pilot with a median 52m followup: Cancer outcomes, treatment-related toxicity and patient-reported QOL Morris, William J.
2008
7 2 p. 123-
1 p.
artikel
35 A single institution comparative study of the potential dosimetric advantages of balloon brachytherapy utilizing multiple lumens and multiple dwells versus single central lumen/central dwell only for accelerated partial breast irradiation Brown, Sheree E.
2008
7 2 p. 142-
1 p.
artikel
36 Assessing the dose to the thyroid for a patient undergoing HDR MammoSite treatment using MOSFET dosimeters Patel, Priti S.
2008
7 2 p. 144-145
2 p.
artikel
37 Association between prostate D90 and severe urinary toxicity-free survival following permanent prostate seed implant Martin, Andre-Guy
2008
7 2 p. 116-
1 p.
artikel
38 Author Index, 2008 World Congress of Brachytherapy 2008
7 2 p. 212-216
5 p.
artikel
39 A virtual fluoroscopy system for seed placement verification Sarkar, Vikren
2008
7 2 p. 99-
1 p.
artikel
40 Benefits of 3D-sonography and MRI integration in gynecological HDR brachytherapy image-guided planning Titova, Vera A.
2008
7 2 p. 126-
1 p.
artikel
41 Biochemical and functional outcomes following brachytherapy in men ≤ 50 years of age with clinically localized prostate cancer Merrick, Gregory S.
2008
7 2 p. 120-121
2 p.
artikel
42 Bladder neck resection prior to I125 LDR brachytherapy improves post-implant urinary toxicity. A matched-pair analysis Voulgaris, Stelios
2008
7 2 p. 117-
1 p.
artikel
43 Brachytherapy for T1-T2 tonsillar carcinoma: Long-term results on 38 patients Harvey, Julie
2008
7 2 p. 128-129
2 p.
artikel
44 Brachytherapy in the treatment of resected keloids Fontanesi, James
2008
7 2 p. 157-
1 p.
artikel
45 Brachytherapy of cancer of the cervix: Comparison of standard and conformal loading by ring and Fletcher suit applicators GhoshDastidar, Aloke
2008
7 2 p. 148-149
2 p.
artikel
46 Brachytherapy with permanent gold grain seeds for squamous cell carcinoma of the lip Cao, Jeffrey Q.
2008
7 2 p. 129-
1 p.
artikel
47 Breast brachytherapy using a balloon catheter, are we really treating just 1 cm beyond the cavity? Quiet, Coral A.
2008
7 2 p. 144-
1 p.
artikel
48 Breast brachytherapy using the AccuBoost system: Dosimetry considerations for tangential irradiation using HDR 192Ir Rivard, Mark J.
2008
7 2 p. 141-
1 p.
artikel
49 Broad beam transmission data for the shielding of brachytherapy facilities ∗ ∗ Work done within the framework of the GEC-ESTRO BRAPHYQS group. Venselaar, Jack
2008
7 2 p. 113-
1 p.
artikel
50 Can we trust the prostate volume derived from computed tomography instead of transrectal ultrasound? Comparison of the prostate volumes on CT and TRUS images in permanent prostate brachytherapy Arimura, Takeshi
2008
7 2 p. 191-
1 p.
artikel
51 Catheters optimization within inverse planning simulated annealing for high-dose-rate brachytherapy Ayotte, Guylaine
2008
7 2 p. 168-
1 p.
artikel
52 Characteristics and outcomes for patients with lung cancer treated with brachytherapy Shirazi, Haider A.
2008
7 2 p. 163-164
2 p.
artikel
53 Characterization of a novel intraocular brachytherapy device Woodward, Benjamin W.
2008
7 2 p. 156-157
2 p.
artikel
54 Characterization of a novel miniature electronic brachytherapy source Verhaegen, Frank
2008
7 2 p. 107-
1 p.
artikel
55 Characterization of the pattern of sexual function after brachytherapy or radical prostatectomy suggests the importance of expectation management Newton, Fiona
2008
7 2 p. 121-
1 p.
artikel
56 Clinical experience with Calypso-guided EBRT following seed implantation Takamiya, Robert K.
2008
7 2 p. 179-
1 p.
artikel
57 Clinical impact of recommended revisions to Cs-131 source data on implant quality indices for prostate permanent seed implants Yaparpalvi, Ravindra
2008
7 2 p. 190-
1 p.
artikel
58 Clinical outcome in 1000 patients with localized prostate cancer treated with external beam radiotherapy and high-dose-rate 192-Iridium brachytherapy boost: A single institution experience Castellanos, Enrique
2008
7 2 p. 93-94
2 p.
artikel
59 Clinical outcome of intermediate-risk prostate cancer patient treated with permanent seeds implant alone: A 10-year clinical experience Vigneault, Eric
2008
7 2 p. 115-
1 p.
artikel
60 Clinical results of conformal high-dose-rate Iridium-192 brachytherapy combined with external beam radiotherapy for localized high-risk prostate cancer Kariya, Shinji
2008
7 2 p. 192-
1 p.
artikel
61 Comparison between graphical optimization and geometrical optimization in HDR interstitial breast implants Saha, Subrata
2008
7 2 p. 129-130
2 p.
artikel
62 Comparison of day 30 to day 1 dosimetry as a function of prostate volume (pv) changes following iodine-125 prostate brachytherapy — proposal for a simple correction factor Bieniek, Eva
2008
7 2 p. 187-
1 p.
artikel
63 Comparison of health related quality of life after the treatment of prostate cancer with permanent seed implantation brachytherapy and radical prostatectomy Saito, Shiro
2008
7 2 p. 121-
1 p.
artikel
64 Comparison of MRI-based treatment planning with transrectal ultrasound for LDR brachytherapy in prostate cancer Miller, Douglas A.
2008
7 2 p. 187-188
2 p.
artikel
65 Comparison of pre- and post-implant urethral dosimetry after low-dose-rate brachytherapy for prostate cancer with a simple contrast injection technique Lassalle, Stephanie
2008
7 2 p. 189-
1 p.
artikel
66 Comparison of scatter doses to the heart, lung, spleen and contralateral breast for whole and partial breast irradiation techniques Pignol, Jean-Philippe
2008
7 2 p. 107-108
2 p.
artikel
67 Comparison of TG43 and Monte Carlo dosimetry for seed-in-mesh brachytherapy for thoracic malignancies Sheu, Ren-Dih
2008
7 2 p. 127-
1 p.
artikel
68 Computed tomography-based dose-volume parameters of the rectum and late rectal complications in patients with cervical carcinoma treated by high-dose-rate intracavitary brachytherapy Kato, Shingo
2008
7 2 p. 96-97
2 p.
artikel
69 Consequence of varying target coverage and dose heterogeneity in accelerated partial breast irradiation brachytherapy modalities on tumor control probability Kirk, Michael C.
2008
7 2 p. 106-
1 p.
artikel
70 Conservative surgery, external radiotherapy and high-dose-rate brachytherapy in early breast cancer: Chronic toxicity and esthetic assessment Perez, Aurora Rodriguez
2008
7 2 p. 141-
1 p.
artikel
71 Correlation between biochemical survival and radiobiological parameters in permanent prostate brachytherapy Butler, Wayne M.
2008
7 2 p. 114-
1 p.
artikel
72 Correlation of a bioeffect model with tumor control in localized prostate cancer treated with low-dose-rate brachytherapy Haworth, Annette
2008
7 2 p. 189-
1 p.
artikel
73 Correlation of Point B and lymph node dose in 3D-planned high-dose-rate cervical cancer brachytherapy Lee, Larissa
2008
7 2 p. 96-
1 p.
artikel
74 CT-based HDR cervix brachytherapy: Early toxicity and results using the Vienna fractionation VanderSpek, Lauren
2008
7 2 p. 146-
1 p.
artikel
75 CT image-based interstitial HDR brachytherapy boost in the conservative treatment of Stage I–II breast cancer – introducing the procedure Kubaszewska, Magda
2008
7 2 p. 145-
1 p.
artikel
76 Depth dose modulation (ddm) for electronic brachytherapy Hiatt, Jessica R.
2008
7 2 p. 106-107
2 p.
artikel
77 Determination of exit skin dose for intracavitary accelerated partial breast irradiation with thermoluminescent dosimeters Raffi, Julie A.
2008
7 2 p. 131-
1 p.
artikel
78 Development of a new Cf-252 source for remote afterloading neutron brachytherapy: Implications and applications Wang, Chris
2008
7 2 p. 161-162
2 p.
artikel
79 Development of the first inverse planning software able to incorporate multiple isotopes into a permanent implant brachytherapy plan Cunha, J. Adam M.
2008
7 2 p. 170-
1 p.
artikel
80 Diagnostic advantages of sublobar resection with vicryl mesh I-125 brachytherapy for early stage non-small cell lung cancer Manning, Matthew
2008
7 2 p. 161-
1 p.
artikel
81 Differences in cause-specific mortality in patients with low-and intermediate-risk prostate cancer treated with brachytherapy, external beam radiotherapy, or radical prostatectomy Ciezki, Jay P.
2008
7 2 p. 118-
1 p.
artikel
82 Differences in prostatic edema in patients treated with Cesium-131 and Palladium-103 for permanent prostate brachytherapy Musmacher, Jeffrey S.
2008
7 2 p. 170-
1 p.
artikel
83 3D image-based dosimetric evaluation of gynecologic high-dose-rate interstitial brachytherapy Sharma, Pramod K.
2008
7 2 p. 135-
1 p.
artikel
84 3D Image-guided brachytherapy Devic, Slobodan
2008
7 2 p. 169-
1 p.
artikel
85 3D image-guided brachytherapy using cone beam CT Reniers, Brigitte
2008
7 2 p. 155-156
2 p.
artikel
86 3D Image-guided gynecologic brachytherapy: Practice patterns in the United States Viswanathan, Akila N.
2008
7 2 p. 110-
1 p.
artikel
87 Displacements and resulting dose effects of tandem ovoid applicators during PDR brachytherapy for cervical cancer De Leeuw, Astrid A.C.
2008
7 2 p. 94-95
2 p.
artikel
88 Does brachytherapy reduce morbidity compared to external beam adaptive radiotherapy or pelvic irradiation with brachytherapy boost for localized prostate cancer? Suen, Andrew W.
2008
7 2 p. 118-
1 p.
artikel
89 Does intraprostatic calcifications affect low-dose-rate brachytherapy? Youssef, Ashraf
2008
7 2 p. 184-185
2 p.
artikel
90 Does skin distance matter with the ClearPath™ multicatheter device for accelerated partial breast irradiation? Haley, Marsha
2008
7 2 p. 130-131
2 p.
artikel
91 Does the addition of real-time intraoperative planning improve dosimetric outcome in prostate brachytherapy? Nobes, Jenny P.
2008
7 2 p. 178-179
2 p.
artikel
92 Do high radiation doses in locally advanced prostate cancer patients treated with Pd-103 implant plus external beam irradiation cause increased urinary, rectal and sexual morbidity? Stone, Nelson N.
2008
7 2 p. 123-
1 p.
artikel
93 Do planned organs-at-risk DVHs represent reality in cervix HDR brachytherapy? A time-based anatomical study Mutyala, Subhakar
2008
7 2 p. 124-
1 p.
artikel
94 Dose escalation prospective phase II study: interstitial pulsed-dose-rate brachytherapy boost for intermediate- and high-risk prostate cancer – early-term outcomes Strnad, Vratislav
2008
7 2 p. 181-
1 p.
artikel
95 Dose homogeneity based dwell time optimization using the adjoint sensitivity guided greedy heuristic algorithm: Application to multicatheter interstitial high-dose-rate brachytherapy for accelerated partial breast irradiation Chaswal, Vibha
2008
7 2 p. 167-
1 p.
artikel
96 Dose measurements in rectum during high-dose-rate brachytherapy using thermoluminescence dosimeters Holmberg, Carina
2008
7 2 p. 172-
1 p.
artikel
97 Dose modeling of the Xoft electronic brachytherapy source for tandem and ovoid applications in patients with cervical cancer Huber, Kathryn
2008
7 2 p. 155-
1 p.
artikel
98 Dose rate measurements around patients with Iodine-125 prostate implants Richardson, C.
2008
7 2 p. 183-184
2 p.
artikel
99 Dosimetric assessment of accelerated partial breast irradiation using CT-guided interstitial brachytherapy Major, Tibor
2008
7 2 p. 141-142
2 p.
artikel
100 Dosimetric comparison of three methods of partial breast irradiation Yashar, Cathryn
2008
7 2 p. 145-
1 p.
artikel
101 Dosimetric correlation of clinical fat necrosis in patients treated with multi-catheter breast brachytherapy Patel, Rakesh R.
2008
7 2 p. 112-
1 p.
artikel
102 Dosimetric effects of an air cavity for a new PBI applicator Richardson, Susan L.
2008
7 2 p. 130-
1 p.
artikel
103 Dosimetric performance of SAVI: A new single-entry, multi-catheter breast brachytherapy applicator Gurdalli, Salih
2008
7 2 p. 142-143
2 p.
artikel
104 Dosimetric predictors for erectile dysfunction in men with prostate cancer treated with permanent interstitial implantation Alicikus, Zumre Arican
2008
7 2 p. 98-99
2 p.
artikel
105 Dosimetry and 2-year potency is improved by hybrid I-125 prostate brachytherapy implant technique Nobes, Jenny P.
2008
7 2 p. 179-
1 p.
artikel
106 3D-planning in HDR brachytherapy of cervical cancer. Analysis of dose volume histograms and clinical correlations Colombo, Alessandro
2008
7 2 p. 110-
1 p.
artikel
107 3D T2-weighted fast recovery fast spin echo sequence MRI for target contouring in cervix cancer brachytherapy Petric, Primoz
2008
7 2 p. 109-110
2 p.
artikel
108 DVH parameters for organs at risk in 3D image-guided interstitial breast brachytherapy Berger, Daniel
2008
7 2 p. 131-
1 p.
artikel
109 Editorial Board 2008
7 2 p. A1-
1 p.
artikel
110 Effect of prostate edema on postimplant dosimetry after Cs-131 brachytherapy Mahmood, Usama
2008
7 2 p. 134-
1 p.
artikel
111 Effect of stranded and loose seeds in relation to prostate edema in permanent I-125 prostate brachytherapy Beiki-Ardakani, Akbar
2008
7 2 p. 133-
1 p.
artikel
112 Endoscopic retrograde HDR-Ir192 intraluminal brachytherapy in biliary cancers Mattiucci, G.C.
2008
7 2 p. 160-161
2 p.
artikel
113 Equivalent phantom sizes in Ir-192 source brachytherapy dosimetric studies Rivard, Mark J.
2008
7 2 p. 137-138
2 p.
artikel
114 Equivalent uniform dose, D 90, and V 100 correlation with biochemical control after low-dose-rate prostate brachytherapy for clinically low-risk prostate cancer Miles, Edward F.
2008
7 2 p. 206-211
6 p.
artikel
115 Evaluation of acute and late toxicity in locally advanced gynecological malignancies treated with interstitial brachytherapy using MUPIT Patel, Pooja Nandwani
2008
7 2 p. 125-
1 p.
artikel
116 Evaluation of collapsed cone dose calculation accuracy for multiple source implants Tedgren, Asa Carlsson
2008
7 2 p. 136-
1 p.
artikel
117 Evaluation of 192Ir high-dose-rate rectal brachytherapy treatment plans using a fast Monte Carlo photon transport code Poon, Emily
2008
7 2 p. 166-
1 p.
artikel
118 Evaluation of semiconductor probes as a tool for in-vivo dosimetry in HDR gynecological brachytherapy Dzingwa, Admire
2008
7 2 p. 171-
1 p.
artikel
119 Evaluation of the TG-43 formalism for dose calculations around curvilinear brachytherapy sources Aryal, Prakash
2008
7 2 p. 169-170
2 p.
artikel
120 Exploration of the optimal dwell positions in intracavitary brachytherapy for cervical cancer Hunte, Aisha
2008
7 2 p. 97-98
2 p.
artikel
121 External beam radiotherapy and interstitial brachytherapy, with or without chemotherapy in the conservative treatment of anal canal carcinoma Shrivastava, Shyam Kishore
2008
7 2 p. 102-
1 p.
artikel
122 External beam radiotherapy and interstitial implant boost in early oral cavity cancer: Experience of initial 23 consecutive cases from a new brachytherapy center in India Dutta, Debnarayan
2008
7 2 p. 163-
1 p.
artikel
123 Favorable clinical outcomes of three-dimensional computer optimized high-dose-rate brachytherapy in the management of localized prostate cancer Deutsch, Israel
2008
7 2 p. 184-
1 p.
artikel
124 FDG PET/CT in head and neck brachytherapy Strnad, Annedore R.
2008
7 2 p. 165-
1 p.
artikel
125 Feasibility and preliminary experiences of choline-PET/CT imaging for salvage HDR brachytherapy for local recurrences of previous irradiated prostate cancer Niehoff, Peter
2008
7 2 p. 101-
1 p.
artikel
126 Feasibility of wedge resection with permanent I-125 brachytherapy for early lung cancer in a community setting Manning, Matthew A.
2008
7 2 p. 157-158
2 p.
artikel
127 Final results of a prospective study of MR-based interstitial gynecologic brachytherapy Viswanathan, Akila N.
2008
7 2 p. 148-
1 p.
artikel
128 Final tolerance and acceptance results of a phase I/II clinical trial of permanent breast 103Pd seed implant Pignol, Jean-Philippe
2008
7 2 p. 111-
1 p.
artikel
129 Five-year biochemical and clinical outcomes for high-dose-rate and low-dose-rate brachytherapy in the setting of favorable risk prostate cancer McGrath, Samuel
2008
7 2 p. 94-
1 p.
artikel
130 Five-year followup for MammoSite APBI – from a single community practice Amendola, Beatriz E.
2008
7 2 p. 143-144
2 p.
artikel
131 Five-year results for accelerated partial breast irradiation using MammoSite® balloon brachytherapy: The first 100 patients Adkison, Jarrod
2008
7 2 p. 104-
1 p.
artikel
132 GliaSite brachytherapy for recurrent malignant gliomas Cooper, Samuel L.
2008
7 2 p. 128-
1 p.
artikel
133 Guide for Authors 2008
7 2 p. A8-
1 p.
artikel
134 HDR boost (real-time) in patients with localized prostate cancer: technical description and preliminary results Spira, Gregor
2008
7 2 p. 188-
1 p.
artikel
135 HDR brachytherapy for primary or recurrent head and neck cancers: A retrospective analysis of the McGill experience AlHamad, Abdulaziz N.
2008
7 2 p. 158-
1 p.
artikel
136 HDR brachytherapy for skin cancers Piro, Fabrizio
2008
7 2 p. 128-
1 p.
artikel
137 HDR brachytherapy for the treatment of skin cancers using standard surface applicators Gauden, Stan
2008
7 2 p. 159-
1 p.
artikel
138 HDR brachytherapy tandem and ovoid titanium applicator safety assessment in 3T MRI Nixon, Earl
2008
7 2 p. 135-136
2 p.
artikel
139 HDR breast boost after conservative surgery: A comparison of cosmetic outcome between intraoperative and postoperative applicator placement Gangopadhyay, Aparna
2008
7 2 p. 140-141
2 p.
artikel
140 HDR clock reproducibility without source transit contribution Saez-Beltran, Moises
2008
7 2 p. 175-
1 p.
artikel
141 HDR interstitial brachytherapy for locally advanced cervix cancer – experience of 18 Gy in two-fraction schedule Gangopadhyay, Aparna
2008
7 2 p. 125-
1 p.
artikel
142 HDR Valencia skin applicators: A proposed commissioning procedure Perez-Calatayud, Jose
2008
7 2 p. 137-
1 p.
artikel
143 Health-related quality of life two years after treatment in patients with localized prostate cancer Guedea, Ferran
2008
7 2 p. 91-
1 p.
artikel
144 Hepatic distribution of a dual-labeled microsphere for intra-arterial brachytherapy in rabbits Kennedy, Andrew S.
2008
7 2 p. 156-
1 p.
artikel
145 High-dose-rate brachytherapy as monotherapy for favorable-risk prostate cancer. Improved toxicity profile with real-time transrectal ultrasound 3D vs 2D treatment planning and dosimetry Ghilezan, Michel
2008
7 2 p. 92-93
2 p.
artikel
146 High-dose-rate brachytherapy for carcinoma of the uterine cervix: A comparison of fractionation schemes and development of acute toxicity Olson, Anna K.
2008
7 2 p. 154-155
2 p.
artikel
147 High-dose-rate brachytherapy in an outpatient basis with local anesthesia for prostate cancer and hypofractionated external beam radiotherapy: A feasibility report Pellizzon, Antonio C.A.
2008
7 2 p. 191-192
2 p.
artikel
148 High-dose-rate brachytherapy in skin cancers: Patient convenience, local control and cosmetical results Rodriguez, Silvia
2008
7 2 p. 159-
1 p.
artikel
149 High-dose-rate brachytherapy in the treatment of lung cancer – Greatpoland Cancer Center experience Skowronek, Janusz
2008
7 2 p. 127-128
2 p.
artikel
150 High-dose-rate 3D image-based brachytherapy for uterine cervical cancer – evaluation of Japanese cervical cancer protocol based on gynecologic GEC-ESTRO recommendations Sakurai, Hideyuki
2008
7 2 p. 124-
1 p.
artikel
151 High-dose-rate interstitial brachytherapy and lumpectomy as a second conservative treatment for local recurrences of breast cancer Jolicoeur, Marjory
2008
7 2 p. 110-111
2 p.
artikel
152 High-dose-rate interstitial brachytherapy for prostate cancer: Analysis of dose plans on 199 patients Nair, Murali
2008
7 2 p. 188-
1 p.
artikel
153 High-dose-rate intracavitary brachytherapy combined with external radiotherapy for medically inoperable endometrial cancer Jacobson, Geraldine M.
2008
7 2 p. 146-
1 p.
artikel
154 High-dose-rate Rotte ‘Y’ applicator brachytherapy for definitive treatment of medically inoperable endometrial cancer: 10 years results Beriwal, Sushil
2008
7 2 p. 151-152
2 p.
artikel
155 Higher strength seeds for I-125 prostate implants Elliott, Sarah
2008
7 2 p. 190-
1 p.
artikel
156 High quality brachytherapy dose distributions obviate the need for high dose supplemental external beam radiation in patients with higher risk features: Results of a prospective randomized trial Merrick, Gregory S.
2008
7 2 p. 114-115
2 p.
artikel
157 History of Japan's radioactive sources for brachytherapy Yamashita, Takashi
2008
7 2 p. 165-166
2 p.
artikel
158 Hungarian experience on partial breast irradiation versus whole breast irradiation: 12-year results of a phase II trial and updated results of a randomized study Polgar, Csaba
2008
7 2 p. 91-92
2 p.
artikel
159 Hypofractionated external beam radiotherapy and single fraction HDR brachytherapy: Improving the results in the treatment of intermediate-risk prostate cancer Duclos, Marie
2008
7 2 p. 119-
1 p.
artikel
160 Image-based 3D treatment planning for postoperative vaginal cylinder brachytherapy: Dose-volume histograms of the bladder, rectum, and bowel Hung, Jennifer
2008
7 2 p. 148-
1 p.
artikel
161 Image-guided HDR intracavitary and interstitial brachytherapy for locally advanced cervix cancer – correlation of late toxicity with DVH data and 3-year outcome analysis Saha, Subrata
2008
7 2 p. 98-
1 p.
artikel
162 Imaging of a 90Y and 111In dual-labeled radioactive microsphere for intra-arterial brachytherapy: An in vivo study in a rabbit liver model Kennedy, Andrew S.
2008
7 2 p. 159-
1 p.
artikel
163 Impact of intraoperative technology on seed migration for loose seed prostate implants Beaulieu, Luc
2008
7 2 p. 167-
1 p.
artikel
164 Impact of multi-channel Wright applicator on vaginal cuff recurrences in endometrial cancer Wilson, William A.
2008
7 2 p. 150-
1 p.
artikel
165 Impact of prescription dose, dose rate, plaque size, and source loading using Pd-103, I-125, and Cs-131: a modern assessment of eye plaque dosimetry Rivard, Mark J.
2008
7 2 p. 104-
1 p.
artikel
166 Impact of the rectosigmoid junction location on dose assessment for rectum and sigmoid in MRI-based cervix cancer brachytherapy Lang, Stefan
2008
7 2 p. 95-96
2 p.
artikel
167 Improved prostate cancer control with the use of HDR brachytherapy boost Millar, Jeremy L.
2008
7 2 p. 120-
1 p.
artikel
168 Improved 10-year outcomes for prostate cancer patients with Gleason 7-10 treated with high-dose-rate brachytherapy boost in the PSA era Swanson, Todd A.
2008
7 2 p. 93-
1 p.
artikel
169 Increased survival after early loading of GliaSite brachytherapy in the treatment of resected solitary brain metastases Ferrier, Moira C.
2008
7 2 p. 162-
1 p.
artikel
170 Influence of Pro-Qura feedback on rectal dosimetry following permanent prostate brachytherapy Sylvester, John
2008
7 2 p. 121-122
2 p.
artikel
171 Initial comparison of 3T vs. 1.5T MR imaging as an adjunct to CT scanning for permanent prostate implant dosimetric assessment Sloboda, Ron
2008
7 2 p. 183-
1 p.
artikel
172 Intercomparison of stranded seeds and loose seed from seedselectron Battermann, Jan J.
2008
7 2 p. 177-
1 p.
artikel
173 Interfraction 3-dimensional variation in position of bladder and rectal hotspots during image-based HDR brachytherapy of the cervix: Are we overestimating the dose to the organs at risk? Vali, Faisal S.
2008
7 2 p. 92-
1 p.
artikel
174 Interstitial HDR boost in the treatment of localized prostate carcinoma – our results Soumarova, Renata
2008
7 2 p. 193-194
2 p.
artikel
175 Interstitial high-dose-rate brachytherapy as monotherapy for early stage prostate cancer Mark, Rufus J.
2008
7 2 p. 181-
1 p.
artikel
176 Interstitial high-dose-rate brachytherapy combined or not with external beam radiotherapy for recurrent cervical cancer. Can it compensate marginal surgical resections? Pellizzon, Antonio C.A.
2008
7 2 p. 165-
1 p.
artikel
177 Interstitial high-dose-rate brachytherapy for early stage breast cancer: A report of 162 cases using multi-catheter technique Mark, Rufus J.
2008
7 2 p. 111-
1 p.
artikel
178 Interstitial high-dose-rate brachytherapy + IMRT vs. HDR monotherapy for early stage prostate cancer Mark, Rufus J.
2008
7 2 p. 93-
1 p.
artikel
179 Interstitial high-dose-rate brachytherapy under local anesthesia for early stage prostate cancer Mark, Rufus J.
2008
7 2 p. 193-
1 p.
artikel
180 Interstitial low-dose-rate mono-brachytherapy with I-125 relapse-free survival and dosimetric outcome for localized prostate cancer in a single European institution Neubauer, Stephan
2008
7 2 p. 118-119
2 p.
artikel
181 Interstitial pulsed-dose-rate brachytherapy alone for low-risk prostate cancer – first experiences of a dose escalation single institution prospective phase II study Geiger, Mathias
2008
7 2 p. 188-189
2 p.
artikel
182 Interstitial template-based high-dose-rate brachytherapy in the treatment of primary and recurrent pelvic malignancies Powell, John W.
2008
7 2 p. 150-
1 p.
artikel
183 Intraoperative brachytherapy in the management of high-risk neck node metastasis: Two case reports from Rajiv Gandhi Cancer Institute Bagga, Preeti
2008
7 2 p. 166-
1 p.
artikel
184 Intraoperative high-dose-rate brachytherapy using 170thulium radiation sources Munro, John J.
2008
7 2 p. 160-
1 p.
artikel
185 Intraoperative prostate brachytherapy – can image-guided implants improve acute side effects with consistently high dosimetry? Husain, Siraj
2008
7 2 p. 186-
1 p.
artikel
186 Intraoperative real-time planning prostate brachytherapy: Pre-treatment prostate volume is no longer an exclusion criterion Duggleby, Stuart
2008
7 2 p. 133-
1 p.
artikel
187 In vitro analysis of 111In for diagnostic imaging in microsphere brachytherapy Kurtzman, Steven
2008
7 2 p. 134-135
2 p.
artikel
188 IPSS trends for Cs-131 permanent prostate brachytherapy Jones, Andrew
2008
7 2 p. 194-
1 p.
artikel
189 Isodose contours and depth-dose behavior of multi-catheter breast applicators Axelrod, Steve
2008
7 2 p. 174-
1 p.
artikel
190 Is real-time intraoperative planning a true surrogate for post-implant dosimetry in Cs-131 prostate brachytherapy? Smith, Ryan P.
2008
7 2 p. 180-181
2 p.
artikel
191 Is there an advantage of serial CT simulation-based 3D planning for every fraction in patients with cervical cancer treated with high-dose-rate brachytherapy? Kim, Hayeon
2008
7 2 p. 125-
1 p.
artikel
192 LDR brachytherapy dose calculation with a fast Monte Carlo code Furstoss, Christophe
2008
7 2 p. 168-
1 p.
artikel
193 LDR brachytherapy for prostate cancer: An analysis of outcomes for the first 1006 consecutive patients treated at the BC Cancer Agency Morris, William J.
2008
7 2 p. 99-
1 p.
artikel
194 LDR prostate planning optimization: incorporating institutional loading and configuration preferences into an automatic planning algorithm Chng, Nick
2008
7 2 p. 185-
1 p.
artikel
195 Listing of Plenary, Oral and Poster Presentations of the 2008 World Congress of Brachytherapy Co-sponsored by the American Brachytherapy Society and GEC-ESTRO 2008
7 2 p. 72-90
19 p.
artikel
196 Local control, cosmetic outcome and radiation sequelae in women treated with accelerated partial breast irradiation using multicatheter brachytherapy Budrukkar, Ashwini N.
2008
7 2 p. 140-
1 p.
artikel
197 Local control, toxicity and cosmesis in women younger than 50 enrolled on the american society of breast surgeons mammosite® RTS registry trial Khan, Atif J.
2008
7 2 p. 105-
1 p.
artikel
198 Long-term evaluation of HDR breast brachytherapy boost in patients treated with breast conserving surgery resulting in close or positive surgical margins Gauden, Stan
2008
7 2 p. 139-
1 p.
artikel
199 Long-term results of biochemical control for intermediate- and high-risk prostate cancer treated with high-dose-rate brachytherapy and external beam radiotherapy without adjuvant androgen deprivation Pellizzon, Antonio C.A.
2008
7 2 p. 182-
1 p.
artikel
200 Long-term results of function preservation by transrectal ultrasound (TRUS)-guided fractionated HDR brachytherapy boost complementary to external beam radiation ± chemotherapy in anal cancer Kovacs, Gyoergy
2008
7 2 p. 102-103
2 p.
artikel
201 Loose seeds vs. stranded seeds: A comparison of critical organ dosimetry and acute toxicity in 125I permanent implant for low-risk prostate cancer Saibishkumar, Elantholi P.
2008
7 2 p. 200-205
6 p.
artikel
202 Low-dose-rate prostate brachytherapy: Toward an accurate intraoperative postimplant dose evaluation Brunet-Benkhoucha, Malik
2008
7 2 p. 178-
1 p.
artikel
203 Magnetic resonance spectroscopy-observed metabolic activity in prostate during PSA bounce following Iodine-125 brachytherapy Damyanovich, Andrei
2008
7 2 p. 91-
1 p.
artikel
204 Masthead 2008
7 2 p. A2-
1 p.
artikel
205 Measurement of skin dose for MammoSite® patients using GafChromic® EBT film Hanley, Joseph
2008
7 2 p. 143-
1 p.
artikel
206 Measurement of transit time and dose of Ir-192 HDR brachytherapy stepping source using re-entrant chamber Murugan, A.
2008
7 2 p. 175-
1 p.
artikel
207 Monte Carlo aided dose calculation for eye-plaque implant Zhang, Hualin
2008
7 2 p. 173-
1 p.
artikel
208 Monte Carlo dosimetry for the first report of a permanent breast Pd-103 seed implant Afsharpour, Hossein
2008
7 2 p. 136-
1 p.
artikel
209 Monte Carlo simulation of COMS eye plaque brachytherapy Melhus, Christopher S.
2008
7 2 p. 126-127
2 p.
artikel
210 Morbidity and PSA control of EBRT plus LDR brachytherapy boost for intermediate and high risk prostate cancer Koontz, Bridget F.
2008
7 2 p. 190-
1 p.
artikel
211 MR-guided high-dose-rate prostate brachytherapy in a low-field open MRI unit: Feasibility and initial experiences Lakosi, Ferenc
2008
7 2 p. 176-177
2 p.
artikel
212 MRI based treatment planning in gynaecological brachytherapy Perez-Calatayud, Jose
2008
7 2 p. 147-
1 p.
artikel
213 MRI-compatible pneumatic robot (MRBot) for prostate brachytherapy: Preclinical evaluation of feasibility and accuracy Song, Danny Y.
2008
7 2 p. 177-178
2 p.
artikel
214 Multiple channel, adjustable applicator device for MR image-guided brachytherapy: Augmentation of management options in locally advanced cervical cancer Hadjiev, Janaki S.
2008
7 2 p. 151-
1 p.
artikel
215 Neoadjuvant high-dose-rate endorectal brachytherapy leads to a high sphincter preservation rate in patients with low rectal cancer Vuong, Te
2008
7 2 p. 103-
1 p.
artikel
216 New laser technologies – photodynamic therapy and local interstitial thermotherapy – as universal radiosensitizers for locally advanced and recurrent gynecological cancer brachytherapy: The pilot study Titova, Vera A.
2008
7 2 p. 154-
1 p.
artikel
217 No difference in tumor control between LDR and PDR as a brachytherapy boost in the conserving management of breast cancer Kolff, M.W.
2008
7 2 p. 111-112
2 p.
artikel
218 Novel catheter patterns for HDR prostate brachytherapy Cunha, J. Adam M.
2008
7 2 p. 177-
1 p.
artikel
219 One size fits all? A case for varying Palladium-103 seed activity based on prostate volume Wernick, Iddo K.
2008
7 2 p. 132-
1 p.
artikel
220 On the radiobiologic implications for intracavitary HDR brachytherapy of cervical carcinoma based on 3D CT imaging and Gynecological GEC-ESTRO recommendations Kim, Yusung
2008
7 2 p. 168-
1 p.
artikel
221 Optimization-based thermal treatment planning platform for catheter-based ultrasound hyperthermia in conjunction with HDR brachytherapy Chen, Xin
2008
7 2 p. 138-139
2 p.
artikel
222 Optimizing radiation protection for an or utilizing modular shielding with Monte Carlo simulation Toye, Warren
2008
7 2 p. 138-
1 p.
artikel
223 Orthogonal film-based vs. 3D image-guided brachytherapy for cervical cancer: Does it make a difference to our patients? Kelly, Tracy
2008
7 2 p. 126-
1 p.
artikel
224 Outcome of prostate cancer patients treated with combined high-dose-rate prostate brachytherapy and external beam radiotherapy at the Windsor Regional Cancer Centre Springer, Colvin D.
2008
7 2 p. 190-
1 p.
artikel
225 Outcomes following surgery and adjuvant radiation in stage II endometrial adenocarcinoma Cannon, George M.
2008
7 2 p. 108-109
2 p.
artikel
226 Outpatient HDR brachytherapy in combination with IMRT and IGRT±ADT in the treatment of low-, intermediate-, and high-risk prostate cancer Dahlbeck, Scott
2008
7 2 p. 192-193
2 p.
artikel
227 Patterns of death following permanent prostate brachytherapy Bittner, Nathan
2008
7 2 p. 117-
1 p.
artikel
228 PDR brachytherapy combined with hyperthermia in head and neck recurrences – Greatpoland Cancer Center preliminary results Chichel, Adam
2008
7 2 p. 158-
1 p.
artikel
229 Perioperative brachytherapy±intensity modulated radiotherapy with or without chemotherapy for carcinoma of the oral tongue Bahoric, Boris
2008
7 2 p. 129-
1 p.
artikel
230 Perioperative interstitial irradiation as a boost in breast conserving therapy Van der Steen-Banasik, Elzbieta M.
2008
7 2 p. 144-
1 p.
artikel
231 Permanent lung implants: How many seeds? Cohen, Gil'ad N.
2008
7 2 p. 170-171
2 p.
artikel
232 Permanent prostate brachytherapy preplannned technique: The modern Seattle method step by step and dosimetric outcomes Sylvester, John E.
2008
7 2 p. 186-
1 p.
artikel
233 Permanent prostate brachytherapy using real-time dosimetry combined with intraoperatively built custom links of seeds provides equivalent dosimetric results as traditional gun applicators Zauls, Andris J.
2008
7 2 p. 187-
1 p.
artikel
234 Photodynamic therapy and laser interstitial thermotherapy in organ-preserve multimodal treatment of primary and recurrent oral cancer Titova, Vera A.
2008
7 2 p. 158-
1 p.
artikel
235 Planning using IPSA reduces dosimetric sensitivity on catheter positioning and number of catheters in prostate HDR brachytherapy Pouliot, Jean
2008
7 2 p. 185-
1 p.
artikel
236 Potential radiobiologic advantages for prostate cancer brachytherapy using multi-isotope seeds composed of a mixture of I-125 and Pd-103 Warren, Graham W.
2008
7 2 p. 157-
1 p.
artikel
237 Pre-biopsy prostate-specific antigen velocity does not predict Gleason score, tumor location or cancer volume following transperineal template-guided prostate mapping biopsy Brammer, Sarah G.
2008
7 2 p. 134-
1 p.
artikel
238 Predictors of cosmesis in women enrolled on the American Society Of Breast Surgeons MammoSite® Registry Trial Khan, Atif J.
2008
7 2 p. 105-
1 p.
artikel
239 Pre-implant prostate size predicts post-implant swelling: The need for variable prostate expansions for implant planning McLaughlin, Patrick W.
2008
7 2 p. 133-
1 p.
artikel
240 Preliminary results of a prospective multicentric French study of PDR 3D brachytherapy for cervix carcinoma Brunaud, Christine
2008
7 2 p. 96-
1 p.
artikel
241 Preliminary results of Iodine-125 vs. Cesium-131 randomized trial on urinary morbidity following brachytherapy for localized prostate cancer Moran, Brian J.
2008
7 2 p. 119-
1 p.
artikel
242 Preliminary results on biochemical control of external beam radiotherapy combined with a PDR boost for prostate cancer Pieters, Bradley
2008
7 2 p. 186-187
2 p.
artikel
243 Prescription dose evaluation in I-125 LDR prostate brachytherapy: Effect of the prostatic volume Bourel, Victor J.
2008
7 2 p. 133-134
2 p.
artikel
244 Present status of brachytherapy in Japan: A survey result Nishimura, Tetsuo
2008
7 2 p. 165-
1 p.
artikel
245 Previous transurethral resection of the prostate is not a contraindication for interstitial high-dose-rate brachytherapy for prostate cancer Mark, Rufus J.
2008
7 2 p. 182-
1 p.
artikel
246 Probabilistic analysis of the planning and delivery of partial breast irradiation with balloon brachytherapy: Unsettling uncertainty Todor, Dorin A.
2008
7 2 p. 139-
1 p.
artikel
247 Prospective analysis of long-term health-related quality-of-life after permanent brachytherapy for prostate cancer Derakhshani, Pedram
2008
7 2 p. 117-
1 p.
artikel
248 Prospective study on quality-of-life and toxicity of high-dose-rate brachytherapy as an interstitial boost for localized prostate cancer Derakhshani, Pedram
2008
7 2 p. 116-
1 p.
artikel
249 Prostate brachytherapy in men ≥75 years of age Merrick, Gregory S.
2008
7 2 p. 186-
1 p.
artikel
250 Prostate cancer control and survival in Vietnam veterans exposed to Agent Orange Everly, Lydia
2008
7 2 p. 185-
1 p.
artikel
251 Prostate volume changes contribute to increase in rectal dose between day 0 and day 30 following permanent prostate brachytherapy Bittner, Nathan H.J.
2008
7 2 p. 132-
1 p.
artikel
252 Prostogram-predicted brachytherapy outcomes may not be universally accurate: An analysis based on The M.D. Anderson Cancer Center experience with I-125 brachytherapy Frank, Steven J.
2008
7 2 p. 99-100
2 p.
artikel
253 Protective effect on the urinary bladder mucosa of intravesical hyaluronic acid in cervix cancer patients treated with pelvic radiotherapy, weekly chemotherapy and high-dose-rate brachytherapy Patino, E. Gonzalez
2008
7 2 p. 152-153
2 p.
artikel
254 Qualitative research to improve patient perception of care: A prostate brachytherapy patient focus group Beaufort, Catherine
2008
7 2 p. 193-
1 p.
artikel
255 Quality control in pulsed dose rate brachytherapy with Ir-192 afterloading system: The use of radiochromic films Bonnet, J.
2008
7 2 p. 174-
1 p.
artikel
256 Quantitative estimation of dose to salivary glands from use of brachytherapy in head and neck cancers Bhalavat, Rajendra L.
2008
7 2 p. 127-
1 p.
artikel
257 Radiation safety with permanent I-125 lung brachytherapy Carey, Elizabeth
2008
7 2 p. 164-
1 p.
artikel
258 Radiochemotherapy and HDR brachytherapy in IIIB cervical cancer patients: Tolerance and efficacy Raczek-Zwierzycka, Katarzyna
2008
7 2 p. 151-
1 p.
artikel
259 Radiochromic film dosimetry for model 6711 I-125 seed with special emphasis on eye plaque applications Chiu-Tsao, Sou-Tung
2008
7 2 p. 137-
1 p.
artikel
260 Real-time brachytherapy dosimetry: Clinical application of a plastic scintillation dosimeter Lambert, Jamil
2008
7 2 p. 113-
1 p.
artikel
261 Recommendations for permanent prostate brachytherapy with 131Cs: A consensus report from the Cesium Advisory Group Bice, William S.
2008
7 2 p. 100-
1 p.
artikel
262 Recommendations for QC of low-photon-energy emitting seeds in brachytherapy Rijnders, Alex W.
2008
7 2 p. 138-
1 p.
artikel
263 Registered ultrasound and fluoroscopy for intraoperative dynamic dosimetry in prostate brachytherapy Song, Danny Y.
2008
7 2 p. 102-
1 p.
artikel
264 Relationship of late urinary morbidity and the biologically effective dose of I-125 permanent prostate brachytherapy with or without external beam radiotherapy Yorozu, Atsunori
2008
7 2 p. 184-
1 p.
artikel
265 Results of high-dose-rate endocavitary brachytherapy in stage IB cervical carcinoma Coza, Ovidiu
2008
7 2 p. 153-
1 p.
artikel
266 Review of permanent interstitial 125I prostate brachytherapy patients treated with biochemical failure and a minimum of 4 years followup Thompson, Anna C.
2008
7 2 p. 116-
1 p.
artikel
267 Ringing the changes: Introducing 3D image-based brachytherapy into routine practice, the Leeds Experience – Phase 1: Doses to OAR Orton, C. Jane
2008
7 2 p. 146-147
2 p.
artikel
268 Robotic needle positioner for ultrasound-guided prostate brachytherapy Song, Danny Y.
2008
7 2 p. 176-
1 p.
artikel
269 Robotic system for image-guided prostate seed implant Podder, Tarun
2008
7 2 p. 100-101
2 p.
artikel
270 Role of brachytherapy in limiting the dose to dysphagia/aspiration related structures in patients of oropharyngeal cancers treated with conventional external beam radiotherapy Mohindra, Pranshu
2008
7 2 p. 156-
1 p.
artikel
271 Role of HDR brachytherapy with standardized surface applicators in the treatment of superficial malignant skin lesions Ghaly, Maged
2008
7 2 p. 159-160
2 p.
artikel
272 Role of high-dose-rate brachytherapy as palliative treatment for obstructive malignant jaundice Mattiucci, G.C.
2008
7 2 p. 166-
1 p.
artikel
273 Second conservative treatment for ipsilateral breast cancer recurrence using interstitial high-dose-rate brachytherapy: Acute toxicity and dosimetric considerations Hannoun-Levi, Jean-Michel
2008
7 2 p. 139-140
2 p.
artikel
274 Seed imaging and reconstruction quality of different CT parameters and various seed models Siebert, Frank-Andre
2008
7 2 p. 112-113
2 p.
artikel
275 Seroma development following intraoperative MammoSite breast brachytherapy: Incidence and contributing factors Ravi, Akkamma
2008
7 2 p. 140-
1 p.
artikel
276 Serum PSA testing frequency: A potent indicator of biochemical and clinical failure Ciezki, Jay P.
2008
7 2 p. 115-116
2 p.
artikel
277 Should the organs at risk be contoured in vaginal cuff brachytherapy? An analysis of within-patient variance Holloway, Caroline L.
2008
7 2 p. 147-148
2 p.
artikel
278 Single vs customized treatment planning for multifraction intracavitary HDR brachytherapy for cervical cancer: Do we need to take the extra step? Chi, Alexander
2008
7 2 p. 97-
1 p.
artikel
279 Skin and chest wall dose with multi-catheter and MammoSite® breast brachytherapy: Implications for late toxicity Cuttino, Laurie
2008
7 2 p. 105-106
2 p.
artikel
280 Skin dose measurement for a high-dose-rate brachytherapy treatment: A phantom study using radiochromic film dosimetry Chiu-Tsao, Sou-Tung
2008
7 2 p. 107-
1 p.
artikel
281 Skirt vs stand applicator immobilization system in vaginal cylinder HDR brachytherapy Yaparpalvi, Ravindra
2008
7 2 p. 152-
1 p.
artikel
282 Spatial relationship of the 3D dose distribution from brachytherapy and external beam therapy for adding both dose plans in patients with cervix cancer Frohlich, Georgina
2008
7 2 p. 95-
1 p.
artikel
283 Table of Contents 2008
7 2 p. A5-
1 p.
artikel
284 TG-43 parameterization of a novel multi-radioisotope brachytherapy source Meigooni, Ali S.
2008
7 2 p. 171-172
2 p.
artikel
285 The delivery of high-dose-rate brachytherapy for cervix cancer: a systematic review. A quality initiative of the program in evidence-based care, Cancer Care Ontario Falkson, Conrad B.
2008
7 2 p. 152-
1 p.
artikel
286 The dosimetric quality of mesh brachytherapy implant following wedge resection of early lung cancer Houser, Christopher J.
2008
7 2 p. 169-
1 p.
artikel
287 The effect of androgen deprivation in patients with intermediate-risk prostate cancer Vassil, Andrew D.
2008
7 2 p. 182-183
2 p.
artikel
288 The impact of pretreatment serum testosterone on survival following permanent prostate brachytherapy Merrick, Gregory S.
2008
7 2 p. 180-
1 p.
artikel
289 The importance of rectum and sigmoid 3D dose reporting in LDR brachytherapy Racine, Marie-Lynn
2008
7 2 p. 149-
1 p.
artikel
290 The late toxicity of medium-dose-rate brachytherapy combined with external beam radiotherapy in the treatment of advanced cervical carcinoma Ordeanu, Claudia
2008
7 2 p. 155-
1 p.
artikel
291 The missing link between different DVH parameters for rectum and urethra in prostate brachytherapy Kirisits, Christian
2008
7 2 p. 119-120
2 p.
artikel
292 The need for institution-specific nomograms for the preoperative prediction of seed requirements when intraoperative planning is utilized for LDR prostate brachytherapy Aronowitz, Jesse N.
2008
7 2 p. 131-132
2 p.
artikel
293 Theoretical and benchtop study of a novel means of skin sparing by sculpting dose with the Xoft Axxent source Axelrod, Steve
2008
7 2 p. 108-
1 p.
artikel
294 The role of needle trauma in the development of urinary toxicity following prostate high-dose-rate brachytherapy Antonucci, J. Vito
2008
7 2 p. 122-
1 p.
artikel
295 The use of a tissue expander to improve the therapeutic ratio of adjuvant radiotherapy for retroperitoneal sarcoma Parikh, Rahul R.
2008
7 2 p. 163-
1 p.
artikel
296 The use of high-dose-rate endorectal brachytherapy as a boost in inoperable patients with locally advanced rectal tumors Vuong, Te
2008
7 2 p. 103-
1 p.
artikel
297 Three-dimensional CT treatments pre-planning of I-125 COMS eye plaque implant brachytherapy Garcia Ramirez, Jose L.
2008
7 2 p. 162-
1 p.
artikel
298 Three-dimensional stereotactic seminal vesicle biopsy and brachytherapy of prostate cancer up to 12 years followup Koutrouvelis, Panos G.
2008
7 2 p. 178-
1 p.
artikel
299 Towards evaluating the dosimetric effect of voids on the surface of intracavitary breast brachytherapy balloons Sehgal, Namratta
2008
7 2 p. 173-
1 p.
artikel
300 Toxicity comparison between intraoperative and preloaded permanent prostate seed implant technique Vigneault, Eric
2008
7 2 p. 119-
1 p.
artikel
301 Tracking proficiency trends with prostate brachytherapy in the setting of an automated implant system: Getting beyond the learning curve Ramer, Wanda
2008
7 2 p. 183-
1 p.
artikel
302 Treatment of skin carcinomas using CT-assisted 3D high-dose-rate brachytherapy and custom made surface molds Kovacs, Arpad
2008
7 2 p. 162-
1 p.
artikel
303 Treatment of T3B prostate cancer with a combination of hormonal therapy, permanent brachytherapy and external beam irradiation Skouteris, Vassilios M.
2008
7 2 p. 179-180
2 p.
artikel
304 Treatment planning, quality assurance and treatment delivery using MammoSite™: Pitfalls and remedies Trichter, Samuel
2008
7 2 p. 174-175
2 p.
artikel
305 Tumor spread and pattern of regression of cervix cancer on repetitive MRI. Basis for adaptive brachytherapy Dimopoulos, Johannes
2008
7 2 p. 95-
1 p.
artikel
306 Twenty-five years experience with I-125 for ocular melanoma Fontanesi, James
2008
7 2 p. 162-163
2 p.
artikel
307 Ultrasound-guided transperineal interstitial HDR radiation therapy in recurrent uterine cancer Okuma, Kae
2008
7 2 p. 150-151
2 p.
artikel
308 Uncertainties in assessing sigmoid dose volume parameters in MRI-guided fractionated HDR brachytherapy Sturdza, Alina E.
2008
7 2 p. 109-
1 p.
artikel
309 Uncertainties in photon brachytherapy dosimetry DeWerd, Larry A.
2008
7 2 p. 136-
1 p.
artikel
310 Usefulness of endoscopically-placed radio-opaque clips in the localization of esophageal cancer for endoluminal brachytherapy and external beam radiation therapy Wakil, George
2008
7 2 p. 161-
1 p.
artikel
311 Use of magnetic resonance spectroscopic imaging in prostate brachytherapy Zhu, Yunping
2008
7 2 p. 175-176
2 p.
artikel
312 Use of postoperative brachytherapy in the treatment of keloids Weytens, Evi
2008
7 2 p. 164-
1 p.
artikel
313 Using a customized midline block defined by HDR brachytherapy imaging versus a standard midline block to compare bladder and rectum dose-volume histograms for parametrial boosts in advanced cervical carcinoma Mehta, Keyur J.
2008
7 2 p. 97-
1 p.
artikel
314 Using a medical product: Follow the label or not (case studies in brachytherapy) Heaton, H. Thompson
2008
7 2 p. 172-
1 p.
artikel
315 Vaginal cylindrical applicator: Use of standard plan or individual planning? Jurczyk, Mieczyslawa
2008
7 2 p. 173-174
2 p.
artikel
316 Vaginal vault brachytherapy as sole postoperative treatment for low-risk endometrial cancer Chong, Irene
2008
7 2 p. 195-199
5 p.
artikel
317 Variants in DNA repair genes and their association with late side-effects in prostate brachytherapy patients Keyes, Mira
2008
7 2 p. 122-123
2 p.
artikel
318 Variations of the prostate, Iodine-125 seeds and dose-volume histogram parameters in permanent prostate brachytherapy and its implication: Comparison of day 1 and day 30 dosimetry Arimura, Takeshi
2008
7 2 p. 192-
1 p.
artikel
319 Visual acuity preservation by interdisciplinary approach and perioperative intensity modulated interstitial brachytherapy in intraorbital sarcomas of the child Kovacs, Gyoergy
2008
7 2 p. 103-104
2 p.
artikel
320 What treatment margins should we achieve with Iodine-125 prostate brachytherapy? Patil, Nikhilesh G.
2008
7 2 p. 181-182
2 p.
artikel
321 Which men choose brachytherapy for their low-risk prostate cancer? Taussky, Daniel
2008
7 2 p. 191-
1 p.
artikel
322 2008 World Congress of Brachytherapy Meeting Program 2008
7 2 p. 61-71
11 p.
artikel
323 5-year results using HDR monotherapy for patients with favorable prostate cancer Martinez, Alvaro A.
2008
7 2 p. 92-
1 p.
artikel
                             323 gevonden resultaten
 
 Koninklijke Bibliotheek - Nationale Bibliotheek van Nederland